Compounds > atracurium
Page last updated: 2024-08-23

atracurium and methylprednisolone

atracurium has been researched along with methylprednisolone in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's3 (42.86)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Coursin, DB; Prielipp, RC1
David, WS; Davies, SF; Fluegel, WL; Iber, C; Leatherman, JW1
Baradello, A; Dattola, R; Fodale, V; Girlanda, P; Lucanto, T; Nicolosi, C; Praticò, C; Rodolico, C; Rovere, V; Santamaria, LB1
Fujishima, S; Izumida, H1

Reviews

2 review(s) available for atracurium and methylprednisolone

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
[Pharmacological therapies for ARDS].
    Masui. The Japanese journal of anesthesiology, 2013, Volume: 62, Issue:5

    Topics: Animals; Anticoagulants; Atracurium; Disseminated Intravascular Coagulation; Glycine; Humans; Meta-Analysis as Topic; Methylprednisolone; Neuromuscular Blocking Agents; Protein C; Proteinase Inhibitory Proteins, Secretory; Pulse Therapy, Drug; Randomized Controlled Trials as Topic; Recombinant Proteins; Respiratory Distress Syndrome; Sulfonamides

2013

Other Studies

5 other study(ies) available for atracurium and methylprednisolone

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Prolonged paralysis with atracurium infusion.
    Critical care medicine, 1995, Volume: 23, Issue:6

    Topics: Atracurium; Critical Care; Drug Monitoring; Drug Therapy, Combination; Humans; Methylprednisolone; Paralysis

1995
Muscle weakness in mechanically ventilated patients with severe asthma.
    American journal of respiratory and critical care medicine, 1996, Volume: 153, Issue:5

    Topics: Acute Disease; Adolescent; Adult; Aged; Albuterol; Asthma; Atracurium; Bronchodilator Agents; Cohort Studies; Female; Glucocorticoids; Humans; Incidence; Male; Methylprednisolone; Middle Aged; Muscle Weakness; Muscular Diseases; Neuromuscular Nondepolarizing Agents; Pancuronium; Respiration, Artificial; Retrospective Studies; Risk Factors; Time Factors; Vecuronium Bromide

1996
Acute motor axonal polyneuropathy after a cisatracurium infusion and concomitant corticosteroid therapy.
    British journal of anaesthesia, 2004, Volume: 92, Issue:2

    Topics: Acute Disease; Adult; Atracurium; Drug Interactions; Glucocorticoids; Humans; Male; Methylprednisolone; Neuromuscular Nondepolarizing Agents; Polyneuropathies; Quadriplegia

2004